<DOC>
	<DOCNO>NCT00150306</DOCNO>
	<brief_summary>To evaluate safety efficacy sertraline compare placebo child adolescent ( 6 17 year age ) outpatients Posttraumatic Stress Disorder .</brief_summary>
	<brief_title>A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD</brief_title>
	<detailed_description>This study terminate July 11 , 2007 . The result primary endpoint analysis interim show Zoloft group significantly different placebo primary endpoint therefore decision make terminate trial . The decision terminate trial base safety concern .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Subjects must 6 17 year age maximum age 17 Baseline Visit study . Subjects must diagnosis Posttraumatic Stress Disorder define DSMIV determine Kiddie Schedule Affective Disorders Schizophrenia SchoolAge ChildrenPresent Lifetime Version ( KSADSPL ) . Subjects whose trauma ongoing , live home abuser , expect participate litigation relate trauma course study exclude participation . Subjects likely high risk experience reexposure index trauma .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>